News

 Registrations to the live broadcast sessions are now open.

Have a look at the program of live broadcasts: (click on the dates for quick access).

> Wednesday 5 March 2014 (Afternoon PST)

> Thursday 6 March 2014 (Morning and Afternoon PST)

> Friday 7 March 2014 (Morning PST)

Wednesday 5 March

Plenary 1 MINI-SYMPOSIA: Organ Dysfunction in the Critically Ill Patient: Emerging Concepts (from 13:10 to 15:45 PST)

• Opening Remarks, by Ravindra L. Mehta, MBBS, MD, DM, FACP,
• Human Adaptations to Hypoxia: Lessons for Critical Illness, by Monty Mythen, MB BS, FRCA, MD, FFI
• Prospects for a Vascular Therapy in Sepsis, by Samir Parikh, MD
• Pathophysiology of Critical Illness: The Role of Glycocalyx, by Matthias Jacob, MD
• Critical Care Normality: Individualized Versus Protocolized Care, by Julia Wendon, MD
• Modulating the Human Innate Response: The Iceman Cometh, by Peter Pickkers, MD, PhD
• Spleen the Forgotten Organ in Critical Illness, by Mark D. Okusa, MD
• Acute Lung injury and ARDS: What’s New? by Kathleen Liu, MD, PhD, MAS
• SPECIAL LECTURE: ISN “0 by 25” A Human Rights Case for Health Equity: Acute Kidney Failure in Poor Countries Should No Longer be a Death Sentence, by Giuseppe Remuzzi, MD

Plenary 2 – MINI-SYMPOSIA Acute Kidney Injury (AKI): Pathophysiology (from 14:15-18:30 PST)

• Subclinical AKI: A New Entity, by Claudio Ronco, MD
• The Rising Tide of AKI – Epidemic or Hype?by Edward Siew, MD
• Consequences of Hypoxia in AKI, by Kent Doi, MD
• Community-acquired AKI in Tropical Countries, by Vivek Jha, MD
• Atypical HUS and AKI by Bradley Dixon, MD
• The Furosemide Stress Test: A Means to Evaluate Incipient AKI? by Lakhmir S. Chawla, MD
• Panel Discussion

Thursday 6 March

Plenary 3 – MINI-SYMPOSIA Tribal Customs in Critical Care Nephrology: Why We Do What We Do Part 1 (From 9:45-12:30 PST)

FLUID Management Strategies for Resuscitation and Hemodynamic Support

• Recommendations From ADQI Assessment of Plasma Volume, by Bruce Molitoris, MD
• Diagnostics for Vascular Health, by Monty Mythen, MD
• What Type of Fluid to Give? by Patrick Murray,
• When and How to Give Fluid, by Eric Hoste, MD
• Fluid Mobilization, by Marlies Ostermann, MD

Part 2 At Risk for AKI: What Should We Do?

• ACE/ARB’s: Stop or Continue? by Norbert Lameire, MD
• Focus on Hydration, by Paul Palevsky, MD
• Prevention of AKI in Sepsis, by Michael Joannidis, MD
• Ischemic Preconditioning, by Joe Bonventre, MD
• Statins for AKI: Friend or Foe? by Peter McCullough, MD
• SPECIAL LECTURE Harmonizing Guidelines: Lessons from Surviving Sepsis Campaign, by Phil Dellinger, MD

Plenary 4 MINI SYMPOSIA: Targeting Renal Recovery: Report From the Roundtable (From 14:00- 15:30 PST)

• Epidemiology of Renal Recovery: What do We Know? by Sean Bagshaw, MD, MSc, FRCPC
• Biology of Renal Recovery: Molecules, Mechanism and Pathways, by Mark D. Okusa, MD
• Enhancing Recovery After AKI: Targets and Interventions, by Kathleen Liu, MD, PhD, MA
• The Economics of Renal Recovery, by Andrew D. Shaw, MB FRCA FCCM FFICM
• Management of the AKI Survivor: It Takes a Village, by Chris McIntyre, MD
• Long Term Outcomes After Renal Epithelial Cell Cycle Arrest, by Lakhmir S. Chawla, MD

Plenary 5 MINI SYMPOSIA: Challenges and Controversies in Renal Support and CRRT (From 14:00 to 18:00 PST)

• Circulatory Stress During Dialysis: Contributor to Endotoxemia? by Chris McIntyre, MD
• Can We Use Biomarkers to Refine RRT? by Dinna Cruz, MD, MPH
• Time, Timing and Timeliness: Changing Paradigms for RRT, by Ravindra L. Mehta, MBBS, MD, DM, FACP,
• Intradialytic Hypotension: The Holy Grail for RRT, by Nitin Kohle, MD
• Peritoneal Dialysis: An Alternate CRRT for AKI?by Rajasekara Chakravarthi, MD, DNB (Nephrology)
• Assessing the Impact of AKI on Convalescent Renal Function at Hospital Discharge, by John Prowle, MA MSc MD MRCP FFICM
• Adapting to Adversity: Drug Shortages in CRRT, by Ashita Tolwani, MD
• KIDMO – Kidney Interventions During Membrane Oxygenation, by Geoffrey Fleming, MD

Friday, 7 March

Plenary 6 MINI SYMPOSIA: Raising Awareness of AKI (frrom 7:30-10:15 PST)

•  Leveraging the EMR to Find Out Who Has AKI in Your Center, by Scott Sutherland, MD
• Drug Induced Kidney Injury: Lessons from the O’Brien Center DIRECT Study, by Linda Awdishu, PharmD, MAS
• Predicting AKI in the ICU, by Etienne Macedo, MD, PhD
• Biomarkers in AKI: Ready for Prime Time? by Kianoush Kashani, MD
• eResearch and Big Data: Why Personalized Medicine is Made For AKI, by John A. Kellum, MD
•  How do We Improve Global AKI Medical Education, by Andrew Lewington, MD
• The Changing Face of AKI: Snapshots from Around the World, by Emmanuel Burdmann, MD, PhD, Zoltan Endre, MD, PhD, Vivek Jha, MD, Oliver Joannes-Boyau, MD, Marlies Ostermann, Dr, Li Yang, M

Plenary 7 MINI SYMPOSIA: Emerging Strategies in AKI and Extracorporeal Support (From 10:45-13:00 PST)

• Update from Ongoing and Late Breaking Trials (approx. 10 minutes each)
  • Sean Bagshaw, MD, MSc, FRCPC
  • Robert Brenner, MD
  • Phil Dellinger, MD
  • John A. Kellum, MD
  • Samina Khan, MD
  • Bhupinder Singh, Dr.
  • James A. Tumlin, MD

1. Polymixin Binding Filter for Sepsis: EUPHRATES Trial – Dellinger
2. ZS-9 Trial – Singh
3. Stem Cells for AKI: Allocure Trial – Brenner
4. STARRT Trial Timing of Dialysis – Bagshaw
5. Abbvie Trial for Post Op AKI – Khan
6. Thrasos Trial for Post Cardiac Surgery AKI – Tumlin
7. Topaz Trial – Kellum

• Critical Care Nephrology: Literature Review, by Noel Gibney, MB FRCP(C)

Click here to see the full CRRT 2014 program